Tag: keytruda

Posted on: November 5, 2019 Posted by: earlenehands Comments: 0

Dr. Mok Discusses Next Steps for Pembrolizumab in NSCLC

Tony Mok, MD, a professor in the department of clinical oncology at the Chinese University of Hong Kong, discusses the next steps for pembrolizumab (Keytruda) as a treatment option for patients with non-small cell lung cancer (NSCLC) after the phase III KEYNOTE-042 trial. The current standard indication has been well-defined by a number of available studies as either monotherapy or in combination, says Mok. One of the next steps includes…

Posted on: November 2, 2019 Posted by: earlenehands Comments: 0

Правоохоронці в Києві та Київській області проводять обшуки

Учора оперативними та оперативно-технічними підрозділами Держприкордонслужби України, спільно з представниками Головного слідчого Управління Нацполіції України під процесуальним керівництвом Генеральної прокуратури України, із застосуванням спецпідрозділу «Дозор» Держприкорждонслужби, відповідно до ухвал Печерського районного суду м. Києва проводяться слідчі дії та обшуки на 11 об’єктах в місті Києві та Київській області. Заходи проходяться в рамках кримінальних проваджень за ознаками злочинів передбачених ч.5 ст.191 КК України «Привласнення, розтрата майна або заволодіння ним шляхом зловживання…

Posted on: October 29, 2019 Posted by: earlenehands Comments: 1

Tấm hình tiết lộ tinh túy của giải nobel Y học 2018

Chỉ với tấm hình này các bạn sẽ hiểu rõ tinh túy của giải Nobel Y học 2018 và cơ sở khoa học của Keytruda (pembrolizumab). ————————— Link đăng ký kênh ✨ THANKS FOR WATCHING Please share this video with your friends! source: https://medinaportal.net Xem thêm các bài viết về Sức Khỏe: https://medinaportal.net/category/suc-khoe/

Posted on: October 26, 2019 Posted by: earlenehands Comments: 1

Cancer Patient Perspectives Panel at 2019 CRI Immunotherapy Patient Summit in Boston

Three patients and two caregivers discuss their experiences with cancer immunotherapy: pembrolizumab (Keytruda) for prostate cancer, CAR T cell therapy for pediatric acute lymphoblastic leukemia, and nivolumab (Opdivo) for glioblastoma. #CRIsummit Denise Malone, mom and caregiver of the youngest panelist, Cole, stressed the importance of a team approach throughout his treatment. Cole was one of the first pediatric patients to receive CD-19 targeted chimeric antigen receptor (CAR) T cell therapy…

Posted on: October 24, 2019 Posted by: earlenehands Comments: 0

Pasi A. Jänne, MD, PhD, on treating patients in the 2nd line setting after 1st line Keytruda

Dr. Jänne, Director, Lowe Center for Thoracic Oncology, Director, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine, Harvard Medical School, shares how he would treat 2nd line patients who previously received Keytruda or other PD-L1 targeting agents as a part of 1st line therapy source: https://medinaportal.net Xem thêm các bài viết về Sức Khỏe: https://medinaportal.net/category/suc-khoe/

Posted on: October 21, 2019 Posted by: earlenehands Comments: 0

Prostate Cancer Treatments Keytruda

– Prostate Cancer Treatments Keytruda This video #33 in this series on on man’s journey with stage 4 prostate cancer. Prostate cancer is the most common cancer affecting men in the United States. From 2008 to 2012, the median age of diagnosis of prostate cancer was 66, and the incidence rate was 138 cases per 100,000 men per year. In this video I talk about PSA testing and the immunotherapy…